GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smedi Co Ltd (XKRX:118000) » Definitions » EV-to-FCF

Smedi Co (XKRX:118000) EV-to-FCF : -2.82 (As of May. 04, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Smedi Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Smedi Co's Enterprise Value is ₩50,389 Mil. Smedi Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-17,893 Mil. Therefore, Smedi Co's EV-to-FCF for today is -2.82.

The historical rank and industry rank for Smedi Co's EV-to-FCF or its related term are showing as below:

XKRX:118000' s EV-to-FCF Range Over the Past 10 Years
Min: -1541.73   Med: -6.71   Max: 327.14
Current: -2.75

During the past 13 years, the highest EV-to-FCF of Smedi Co was 327.14. The lowest was -1541.73. And the median was -6.71.

XKRX:118000's EV-to-FCF is ranked worse than
100% of 509 companies
in the Drug Manufacturers industry
Industry Median: 22.78 vs XKRX:118000: -2.75

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-04), Smedi Co's stock price is ₩520.00. Smedi Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-131.000. Therefore, Smedi Co's PE Ratio for today is At Loss.


Smedi Co EV-to-FCF Historical Data

The historical data trend for Smedi Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smedi Co EV-to-FCF Chart

Smedi Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.06 42.74 -61.13 -33.70 -3.77

Smedi Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.70 -16.86 11.89 -1,650.20 -3.77

Competitive Comparison of Smedi Co's EV-to-FCF

For the Drug Manufacturers - General subindustry, Smedi Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smedi Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smedi Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Smedi Co's EV-to-FCF falls into.



Smedi Co EV-to-FCF Calculation

Smedi Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=50388.930/-17892.635
=-2.82

Smedi Co's current Enterprise Value is ₩50,389 Mil.
Smedi Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-17,893 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smedi Co  (XKRX:118000) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Smedi Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=520.00/-131.000
=At Loss

Smedi Co's share price for today is ₩520.00.
Smedi Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-131.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Smedi Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Smedi Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Smedi Co (XKRX:118000) Business Description

Traded in Other Exchanges
N/A
Address
202, 156, Byeongjeomjungang-ro, Jinan-dong, Dream Buildiing, Gyeonggi-do, Hwaseong-si, KOR
Smedi Co Ltd, formerly The Medipharm Co Ltd has established a hospital in Jeju and exports various types of medical equipments. The company also built its own hospital in China and India and plans to expand its business in Spain and Dubai. The Company and its subsidiaries are divided into pharmaceutical business, medical business, wireless device business, investment and others according to business characteristics by business sector.

Smedi Co (XKRX:118000) Headlines

No Headlines